Stock listing
Venus Medtech (hangzhou), Inc. Class H
Selected listing: 2500 · HKEX · HKD · HK
Venus Medtech (hangzhou), Inc. Class H (HKEX:2500), Health Technology. Latest release Sep 30, 2026: POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING.
- Ticker
- HKEX:2500
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- HKEX
- Currency
- HKD
About Venus Medtech (hangzhou), Inc. Class H
The company focuses on developing innovative medical technologies. Its commitment to advancing healthcare solutions positions it as a notable player in the medical device industry.
Latest news from Venus Medtech (hangzhou), Inc. Class H
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING
September 30, 2026
Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement
October 25, 2025
Court Sides with Cardiovalve in Edwards patent spat
August 5, 2025
Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations
April 21, 2025
Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve
January 24, 2022
Research Venus Medtech (hangzhou), Inc. Class H
Venus Medtech (hangzhou), Inc. Class H company profile
View the public company page for Venus Medtech (hangzhou), Inc. Class H on 6ix.
Venus Medtech (hangzhou), Inc. Class H news
Read company news and market updates connected to Venus Medtech (hangzhou), Inc. Class H.
Venus Medtech (hangzhou), Inc. Class H investor events
Find investor webinars, events, and replay context for Venus Medtech (hangzhou), Inc. Class H.